Literature DB >> 19016565

Application of imaging capillary IEF for characterization and quantitative analysis of recombinant protein charge heterogeneity.

Zoran Sosic1, Damian Houde, Andy Blum, Tyler Carlage, Yelena Lyubarskaya.   

Abstract

In this work several aspects of imaging capillary IEF (icIEF) application for charge heterogeneity analysis of recombinant proteins and monoclonal antibodies have been discussed. Advantages of the method as compared with traditional approaches for determination of biomolecule charge heterogeneity, such as gel and IEC, have been demonstrated. Correlation of icIEF-detected protein isoforms with the charge heterogeneity determined by IEC has been shown for a representative recombinant monoclonal antibody. Identification of charged variants collected from IEC has been performed by ESI-MS. Qualification of an icIEF method for use in quality control environment for quantitative analysis of recombinant protein charge heterogeneity and monitoring protein stability has also been discussed. The intermediate precision for determination of pI of main or main acidic species was </=0.2% RSD. Relative % peak areas for acidic, main and basic species were reproducible within 1.9, 0.9 and 16.6% RSD, respectively. Based on the assay performance evaluation, icIEF assay has been shown to allow for fast method development, short analysis time and high sample throughput. Some aspects of the method specificity for use as an identity test in biopharmaceutical development have been discussed.

Mesh:

Substances:

Year:  2008        PMID: 19016565     DOI: 10.1002/elps.200800157

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  8 in total

Review 1.  Analytical methods for physicochemical characterization of antibody drug conjugates.

Authors:  Aditya Wakankar; Yan Chen; Yatin Gokarn; Fredric S Jacobson
Journal:  MAbs       Date:  2011-03-01       Impact factor: 5.857

2.  Capillary Isoelectric Focusing: Mass Spectrometry Method for the Separation and Online Characterization of Monoclonal Antibody Charge Variants at Intact and Subunit Levels.

Authors:  Jun Dai; Qiangwei Xia; Chengjie Ji
Journal:  Methods Mol Biol       Date:  2022

3.  Structural Characterisation of Non-Deamidated Acidic Variants of Erwinia chrysanthemi L-asparaginase Using Small-Angle X-ray Scattering and Ion-Mobility Mass Spectrometry.

Authors:  David Gervais; Darryl King; Patrick Kanda; Nicholas Foote; Lucy Elliott; Phillip Brown; Natacha O Lee; Konstantinos Thalassinos; Claire Pizzey; Robert Rambo; Thomas C Minshull; Mark J Dickman; Stuart Smith
Journal:  Pharm Res       Date:  2015-06-04       Impact factor: 4.200

Review 4.  Protein comparability assessments and potential applicability of high throughput biophysical methods and data visualization tools to compare physical stability profiles.

Authors:  Mohammad A Alsenaidy; Nishant K Jain; Jae H Kim; C Russell Middaugh; David B Volkin
Journal:  Front Pharmacol       Date:  2014-03-12       Impact factor: 5.810

5.  Charge Variants of an Avastin Biosimilar Isolation, Characterization, In Vitro Properties and Pharmacokinetics in Rat.

Authors:  Yan-Yan Zhao; Ning Wang; Wan-Hui Liu; Wen-Jie Tao; Li-Li Liu; Zhen-Duo Shen
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

6.  Qualification of NISTmAb charge heterogeneity control assays.

Authors:  Abigail Turner; John E Schiel
Journal:  Anal Bioanal Chem       Date:  2018-02-09       Impact factor: 4.142

7.  Evaluation of an icIEF-MS system for comparable charge variant analysis of biotherapeutics with rapid peak identification by mass spectrometry.

Authors:  Xiaoping He; Mariam ElNaggar; Maggie A Ostrowski; Andras Guttman; Erik Gentalen; Justin Sperry
Journal:  Electrophoresis       Date:  2022-04-26       Impact factor: 3.595

8.  Structural and Functional Analysis of CEX Fractions Collected from a Novel Avastin® Biosimilar Candidate and Its Innovator: A Comparative Study.

Authors:  Busra Gurel; Melike Berksoz; Eda Capkin; Ayhan Parlar; Meltem Corbacioglu Pala; Aylin Ozkan; Yılmaz Capan; Duygu Emine Daglikoca; Meral Yuce
Journal:  Pharmaceutics       Date:  2022-07-28       Impact factor: 6.525

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.